Maren T H, Godman D R, Pancorbo B M, Vogh B P
Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, USA.
Invest Ophthalmol Vis Sci. 1997 May;38(6):1274-7.
To determine whether the well-known effect of timolol in reducing ocular pressure and aqueous humor (AH) flow is a function of reduced Na+ movement from plasma to aqueous. Previously, the authors have shown this to be the case for carbonic anhydrase inhibitors.
The rate of appearance of 22Na in rabbit posterior aqueous was measured 1 to 3 minutes after the intravenous injection (time T) of the isotope. One hour before this, the animals received one of the following: two drops of 0.5% timolol, two drops of 3.5% pilocarpine, or 25 mg/kg intravenous methazolamide. At 1 minute (T + 1), a posterior chamber sample was taken; 2 minutes later (T + 3) a second sample was removed from the fellow eye. The rate constant of sodium accession is simply the difference between the two counts/2 minutes. Aqueous flow was measured by dilution of sulfacetamide marker as described previously.
The rate constant (k(in)) for sodium entering the posterior chamber was 0.036 +/- 0.004 minute-1 (n = 17). Corresponding to previous findings, methazolamide (25 mg/kg intravenous) reduced this to 0.023 +/- 0.003 minute-1 (n = 14). Conversely, timolol (two drops of 0.5% solution) had no effect on kin, which measured 0.037 +/- 0.004 minute-1 (n = 12). Similarly, as expected, pilocarpine had no effect on k(in) (0.035 +/- 0.003 minute-1). Control flow was 3.9 microliters/minute +/- 0.4; after timolol, 2.5 microliters/minute +/-0.1; after methazolamide, 2.4 microliters/minute +/-0.2; after pilocarpine, 3.6 microliters/minute +/- 0.2. These are converted to rate constants by dividing by volume of posterior aqueous (60 microliters). The control rate constant for fluid entry was 0.065 minute-1, 1.8-fold higher than for sodium.
A central dogma of the formation of AH (and cerebrospinal fluid) is that fluid moves isotonically from plasma to AH or cerebrospinal fluid and, therefore, that rate constant k(in) for fluid and for sodium are approximately the same. In the authors' hands, the fluid constant was modestly higher than for sodium. This holds for normal function and also for the reduced k(in) for fluid and sodium after carbonic anhydrase inhibition. The k(in) for neither flow nor sodium was affected by pilocarpine. Surprisingly, however timolol, which reduces flow, had no effect on Na+ entry.
确定噻吗洛尔降低眼压和房水(AH)生成率的众所周知的作用是否是由于从血浆到房水的Na⁺转运减少所致。此前,作者已证明碳酸酐酶抑制剂的情况就是如此。
在静脉注射同位素后1至3分钟(时间T)测量兔后房水中²²Na的出现率。在此之前1小时,动物接受以下之一:两滴0.5%噻吗洛尔、两滴3.5%毛果芸香碱或25mg/kg静脉注射乙酰唑胺。在1分钟(T + 1)时,采集后房样本;2分钟后(T + 3),从对侧眼取出第二个样本。钠进入房水的速率常数简单地就是两次计数之差除以2分钟。房水生成率通过如前所述的磺胺醋酰标记物稀释法测量。
钠进入后房的速率常数(k(in))为0.036±0.004分钟⁻¹(n = 17)。与先前的发现一致,乙酰唑胺(25mg/kg静脉注射)将其降至0.023±0.003分钟⁻¹(n = 14)。相反,噻吗洛尔(两滴0.5%溶液)对k(in)无影响,k(in)为0.037±0.004分钟⁻¹(n = 12)。同样,如预期的那样,毛果芸香碱对k(in)无影响(0.035±0.003分钟⁻¹)。对照房水生成率为3.9微升/分钟±0.4;噻吗洛尔治疗后为2.5微升/分钟±0.1;乙酰唑胺治疗后为2.4微升/分钟±0.2;毛果芸香碱治疗后为3.6微升/分钟±0.2。通过除以后房房水体积(60微升)将这些转换为速率常数。液体进入的对照速率常数为0.065分钟⁻¹,比钠的速率常数高1.8倍。
房水(和脑脊液)形成的一个核心教条是液体以等渗方式从血浆移动到房水或脑脊液,因此,液体和钠的速率常数k(in)大致相同。在作者的研究中,液体常数略高于钠的常数。这在正常功能以及碳酸酐酶抑制后液体和钠的k(in)降低的情况下均成立。毛果芸香碱对房水生成率和钠进入房水的速率常数均无影响。然而,令人惊讶的是,降低房水生成率的噻吗洛尔对Na⁺进入无影响。